• Agilent and A*STAR's BTI Collaborate on New Bioanalytical Methodologies

News & Views

Agilent and A*STAR's BTI Collaborate on New Bioanalytical Methodologies

Sep 09 2015

Agilent Technologies and the Bioprocessing Technology Institute (BTI), a research institute of Singapore’s Agency for Science, Technology and Research (A*STAR) announced that they will collaborate on new analytical approaches to analysing specific protein-linked sugar compounds. The collaboration will address a gap in analytical tests and standards applied for drugs based on glycoproteins, which now form the majority of approved biopharmaceutical drugs. Current analytical methods for characterising glycans are time-consuming and difficult to deploy in commercial environments. They are also limited in their ability to detect and analyse minor glycan species.

According to Nino Totino, General Manager for Agilent’s Life Sciences and Applied Markets Group in the South Asia, Pacific and Korea region, there is a critical need in the biopharmaceutical industry for a novel technology platform that can support detailed glycan analysis quickly and effectively in a high throughput environment. Both Agilent and BTI will work together on several projects that could lead to the creation of rigorous, standardised tests for drug safety and efficacy.


Digital Edition

Lab Asia 30.2 - April 2023

April 2023

In This Edition Chromatography Articles - On-Column Sample Focussing: a Personal Perspective Mass Spectrometry & Spectroscopy Articles - Multi-scale, multi-modal and operando imaging wi...

View all digital editions

Events

MSACL 2023

Apr 02 2023 Monterey, CA, USA

Analitika Expo 2023

Apr 11 2023 Moscow, Russia

Microbiology Society Annual Conference 2023

Apr 17 2023 Birmingham, UK

Korea Lab 2023

Apr 18 2023 Kintex, South Korea

Analytica Vietnam

Apr 19 2023 Ho Chi Minh City, Vietnam

View all events